DOP2011000267A - Composicion farmaceutica oral para uso en enfermedades respiratorias - Google Patents

Composicion farmaceutica oral para uso en enfermedades respiratorias

Info

Publication number
DOP2011000267A
DOP2011000267A DO2011000267A DO2011000267A DOP2011000267A DO P2011000267 A DOP2011000267 A DO P2011000267A DO 2011000267 A DO2011000267 A DO 2011000267A DO 2011000267 A DO2011000267 A DO 2011000267A DO P2011000267 A DOP2011000267 A DO P2011000267A
Authority
DO
Dominican Republic
Prior art keywords
composition
pharmaceutical composition
respiratory diseases
oral pharmaceutical
release
Prior art date
Application number
DO2011000267A
Other languages
English (en)
Inventor
Juan Aurelio Senosiain Aguilar
Raul Garcia Salgado Lopez
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of DOP2011000267A publication Critical patent/DOP2011000267A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica oral de liberación modificada en cápsulas con microesferas, que contiene loratadina, fenilefrina y vehículos o excipientes farmacéuticamente aceptables; dicha composición presenta una biodisponibilidad inmediata, con valores de concentración plasmática dentro de la ventana terapéutica con una liberación uniforme y continua; se refiere también a un proceso de fabricación de la composición y al uso de dicha composición indicada para el tratamiento como antihistamínico y descongestionante nasal.
DO2011000267A 2009-02-20 2011-08-19 Composicion farmaceutica oral para uso en enfermedades respiratorias DOP2011000267A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2009001925A MX2009001925A (es) 2009-02-20 2009-02-20 Composicion farmaceutica oral para uso en enfermedades respiratorias.

Publications (1)

Publication Number Publication Date
DOP2011000267A true DOP2011000267A (es) 2011-12-31

Family

ID=42633450

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2011000267A DOP2011000267A (es) 2009-02-20 2011-08-19 Composicion farmaceutica oral para uso en enfermedades respiratorias

Country Status (9)

Country Link
US (1) US20120064155A1 (es)
AR (1) AR075058A1 (es)
CO (1) CO6410284A2 (es)
CR (1) CR20110436A (es)
DO (1) DOP2011000267A (es)
HN (1) HN2011002258A (es)
MX (1) MX2009001925A (es)
PE (1) PE20120173A1 (es)
WO (1) WO2010094996A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016044704A1 (en) 2014-09-19 2016-03-24 The Procter & Gamble Company Pulsed release phenylephrine dosage forms
MX2017001192A (es) * 2017-01-26 2018-07-25 Laboratorios Liomont S A De C V Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun.
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255968B (it) * 1992-11-27 1995-11-17 Composizioni farmaceutiche contenenti acido ursodesossicolico
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
PE20080313A1 (es) * 2006-06-01 2008-04-10 Schering Corp Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
NZ573173A (en) * 2006-06-01 2012-03-30 Msd Consumer Care Inc Phenylephrine pharmaceutical formulation and compositions for colonic absorption

Also Published As

Publication number Publication date
PE20120173A1 (es) 2012-03-24
AR075058A1 (es) 2011-03-09
CR20110436A (es) 2011-10-24
US20120064155A1 (en) 2012-03-15
MX2009001925A (es) 2010-08-20
WO2010094996A1 (es) 2010-08-26
HN2011002258A (es) 2014-06-16
CO6410284A2 (es) 2012-03-30

Similar Documents

Publication Publication Date Title
CY1126112T1 (el) Φαρμακοτεχνικες μορφες που περιεχουν ενυδρη προπυλενογλυκολη δαπαγλιφλοζινης
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
UY32177A (es) Tratamiento de diabetes en pacientes con control glucémico insuficiente a pesar de la terapia con fármaco, oral o no, antidiabético
SV2010003451A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
DOP2010000011A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
DOP2006000057A (es) Composición farmaceútica para el tratamiento del cáncer
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
DOP2010000012A (es) Derivados de morfolino pirimidina utilizados en enfermedades relacionadas con mtor quinasa y/o pi3k
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
BRPI0714539B8 (pt) processo para obtenção de forma de dosagem farmaceutica de liberação prolongada de opioides
ECSP088973A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
AR091351A1 (es) Formulaciones de bromocriptina, metodo para mejorar el control glucemico y metodo para la fabricacion
IL206815A (en) Blockers of Triazo and Cyclo Diazu channels, pharmaceuticals including them and their use in the preparation of drugs for the treatment of diseases
PE20140255A1 (es) Tableta dispersable en forma oral
EA201171497A1 (ru) Снижение флуктуаций опиоидов в крови
IL215826A (en) Pharmaceutical preparation with delayed release, process of preparation of the preparation, use of the preparation for the preparation of pain medication and the pill containing it.
DOP2015000028A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
CL2011003371A1 (es) Composicion farmaceutica de dosis fija, oral, solida y estable que comprende irbesartan, besilato de amlodipino y excipientes; procedimientos de preparacion; uso en el tratamiento de la hipertension.
CL2016001707A1 (es) Tratamiento de trastornos congnitivos con (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma (div. sol. 1178-11).
DOP2011000267A (es) Composicion farmaceutica oral para uso en enfermedades respiratorias
AR098716A1 (es) Formas de dosificación farmacéuticas
EP2932967A4 (en) USE OF A LIGHT SENSITIVE AGENT FOR THE MANUFACTURE OF A REACTIVE OXYGEN SPECIES IN THE MANUFACTURE OF A MEDICAMENT FOR THE PHOTODYNAMIC THERAPY OF A DISEASE RELATED TO STEM CELLS, THEIR IN VITRO USE AND PHARMACEUTICAL COMPOSITION
GB0920721D0 (en) An orally administered anthelmintic unit dose tablet and process for the preparation thereof